the International Association of Pancreatology (IAP)|the Japan Pancreas Society (JPS)|the Asian Oceanic Pancreatic Association (AOPA)

Scientific Program

On-line Abstracts

Abstracts have been published in “Pancreatology” in Elsevier. (Japanese abstracts are excluded.)
Please click the URL to download below;
http://www.pancreatology.net/issue/S1424-3903(16)X0008-7

Time Table
The George E. Palade Memorial Lecture
The George E. Palade Memorial Lecture

AUGUST 5 (12:50-13:50) Room 1(Main Hall, Conference building 2F)


Moderators Vay Liang W.(Bill)Go(University of California, USA)
Tooru Shimosegawa(Tohoku University Graduate School of Medicine, Japan)
大槻 眞
My life in pancreatic research―Unexpected results may open the door
Makoto Otsuki(Professor Emeritus, University of Occupational and Environmental Health, Japan)
Special Lectures
Special Lecture 1

AUGUST 4 (14:10-15:00) Room 1(Main Hall, Conference building 2F)

Moderator Yoshifumi Kawarada(Professor Emeritus, Mie University, Japan)
山田 雄司
The Truth about Ninja Summary
Yuji Yamada(Faculty of Humanities, Law and Economics, Mie University, Japan)
  Now the word‘ninja’spreads all over the world. But almost all of the people misunderstand ninja. The real life of ninja have been kept under a veil, but with so many elements to stir our imagination.
  The ninja's principal mission was to gather information. To accomplish this mission, the ninja had to act with stealth and discretion. During the Sengoku (Warring States) period, from the 15th to the 16th century, the ninja may have infiltrated enemy castles, ambushed, disturbed, fought, set fire and so on, but their most important job was to deliver information about the enemy to their master. In order to complete such missions, they needed to avoid combat as much as possible, to survive, and to return alive. Even during peacetime, they had roles such as finding out the circumstance of other countries and delivering information to be used for better governance.
  During the Edo period when the necessity of combat had become rare and the society was at peace, the ninja's professional function was focused more on information gathering. Additionally, the ninja's spirituality was emphasized, the concept of enduring everything by restraining oneself and prioritizing loyalty to one's master was clarified.
  The ninja do not loudly appeal their presence or achievement, but rather focus on executing their mission for their master quietly and with a high level of spirituality. Some people might enjoy the idea that a ninja's mission is kept secret from public but might be significant enough to change the world.

PROFILE

Professor Yūji Yamada is a specialist in medieval Japanese cultural history and serves on the Faculty of Humanities, Law and Economics at Mie University, Japan. He graduated from the Department of History, Faculty of Literature, Kyoto University in 1991. He received the PhD degree from the University of Tsukuba in 1998. His research focuses on the history of vengeful spirits, strange phenomena, Ise shrine, and ninja studies. His most recent publications include The Spirit of Ninja: A Study of the Global Ninja Craze (2015).

Special Lecture 2

AUGUST 6 (10:55-11:55) Room 1(Main Hall, Conference building 2F)

Moderator Shuji Isaji(Mie University Graduate School of Medicine, Japan)
星野 仙一
His interesting experiences from his life as a professional baseball player.
Senichi Hoshino(Vice Chairman of the Board of RAKUTEN BASEBALL, Inc., Japan)
Special Lecture 3

AUGUST 5 (11:30-12:00) Room 1(Main Hall, Conference building 2F)

Moderator Tooru Shimosegawa(Tohoku University Graduate School of Medicine, Japan)
John Neoptolemos
ESPAC-4: A multicenter, international, open label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP), versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
John Neoptolemos
JPS Presidential Lecture
JPS Presidential Lecture

AUGUST 5 (10:50-11:30) Room 1(Main Hall, Conference building 2F)

Moderator Ryuji Mizumoto(Professor Emeritus, Mie University, Japan)
伊佐地秀司
Discipline with refining in my career in pancreatology
Shuji Isaji(Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Japan)
State-of-the-Art Lecture
State-of-the-Art Lecture 1

AUGUST 4 (11:00-11:45) Room 1(Main Hall, Conference building 2F)


Moderator Tooru Shimosegawa(Tohoku University Graduate School of Medicine, Japan)
Ashok K Saluja
Minnelide, a novel therapy against pancreatic cancer:Bench to bedside and back to bench
Ashok K Saluja(Department of Surgery and Sylvester Comprehensive Cancer Center, University of Miami, USA)

State-of-the-Art Lecture 2

AUGUST 5 (10:00-10:45) Room 3(Hagi, Conference building 2F)


Moderator Wataru Kimura(Yamagata University Faculty of Medicine, Japan)
Markus W. Büchler
NET of the Pancreas:Surgical Treatment
Markus W. Büchler(Department of Surgery, University of Heidelberg,Germany)

State-of-the-Art Lecture 3

AUGUST 6 (10:00-10:45) Room 3(Hagi, Conference building 2F)


Moderator Hiroki Yamaue(Wakayama Medical University, Japan)
Matthew HG Katz
New Principles of Pancreatic Cancer Surgery
Matthew HG Katz(Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, USA)

International Consensus
IAP International Consensus 1
Consensus for Treatment of Autoimmune Pancreatitis

AUGUST 4 (8:30-11:00) Room 2(Tachibana, Conference building 2F)

Moderators Kazuichi Okazaki(Kansai Medical University, Japan)
Suresh T Chari(Mayo Clinic, USA)
Markus M. Lerch
Autoimmune pancreatitis-a European perspective
Markus M. Lerch(Department of Medicine A, University Medicine, Ernst-Moritz-Arndt-University of Greifswald, Germany)
Suresh T Chari
Standard treatment of AIP in USA:Is biliary drainage needed in obstructive jaundice before treatment?
Suresh T Chari(Mayo Clinic, USA)
Myung-Hwan Kim
Standard treatment in Korea:When to taper & when to stop on what criteria?
Myung-Hwan Kim(Division of Gastroenterology, University of Ulsan College of Medicine, Korea)
Terumi Kamisawa
Standard treatment for AIP in Japan. Who need and Who don’t need maintenance treatment?
Terumi Kamisawa(Department of Internal Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan)
Atsushi Masamune
Randomized controlled trial of maintenance corticosteroid therapy in patients with autoimmune pancreatitis
Atsushi Masamune(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)
Luca Frulloni
How to treat relapse AIP:steroid, steroid sparing agents or surgery?
Luca Frulloni(Department of Medicine, Institute of the Pancreas, University of Verona, Italy)
Shigeyuki Kawa
Prediction of long-term outcome for autoimmune pancreatitis
Shigeyuki Kawa(Center for Health, Safety and Environmental Management, Shinshu University, Japan)

IAP International Consensus 2
International Consensus on PNET

AUGUST 4 (14:45-16:45) Room 2(Tachibana, Conference building 2F)

Moderators Tetsuhide Ito(Graduate School of Medical Sciences, Kyushu University, Japan)
Robert T. Jensen(National Institutes of Health, USA)
Robert T. Jensen
Advances in management of pancreatic neuroendocrine tumors (pNETs)
Robert T. Jensen(Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA)
Hironobu Sasano
Pathology of PNET update in 2016
Hironobu Sasano(Pathology, Tohoku University School of Medicine, Japan)
Lingaku Lee
Consensus on diagnosis for pancreatic neuroendocrine tumors
Lingaku Lee(Department of Medicine and Bioregulatory science, Kyushu University / Kyushu Rousai Hospital, Japan)
Taku Aoki
Consensus on determinants of tumor resection of pancreatic neuroendocrine tumors
Taku Aoki(Second Department of Surgery, Dokkyo Medical University, Japan)
Massimo Falconi
Consensus on medical treatments for pancreatic neuroendocrine tumors
Massimo Falconi(Surgical Department, University Vita - Salute San Raffaele, Italy)
Robert T. Jensen
Consensus on hereditary tumor syndromes in pancreatic neuroendocrine tumors(pNETs)
Robert T. Jensen(Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA)
Masayuki Imamura
To clearlify the unsolved problems in the treatment of pNET
Masayuki Imamura(Center of Neuroendocrine Tumor, Kansai Electric Power Hospital, Japan)

IAP International Consensus 3
International Consensus on the Management of IPMN

AUGUST 5 (8:15-10:45) Room 2(Tachibana, Conference building 2F)

Moderators Masao Tanaka(Shimonoseki City Hospital, Japan)
Terumi Kamisawa(Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan)
Carlos Fernández-del Castillo(Massachusetts General Hospital / Harvard Medical School, USA)
Carlos Fernández-del Castillo
IPMN:Overview of previous revision and remaining controversies with reference to AGA guidelines
Carlos Fernández-del Castillo(Department of General and Gastrointestinal Surgery, Massachusetts General Hospital / Harvard Medical School, USA)
Philippe Lévy
IPMN:What is adequate interval of surveillance?
Philippe Lévy(Department of Gastroenterology and Pancreatology, Hospital Beaujon, France)
Minoru Tada
Is it ever safe to stop surveillance?
Minoru Tada(Department of Gastroenterology, The University of Tokyo, Japan)
Jin-Young Jang
Does the cyst size matter in determining frequency of surveillance?
Jin-Young Jang(Department of Surgery, Seoul National University Hospital, Korea)
Christopher L. Wolfgang
Should we do surveillance after resection?
Christopher L. Wolfgang(Johns Hopkins Hospital, USA)
Takao Ohtsuka
Can we predict what may happen in the remnant pancreas after partial pancreatectomy for IPMN?
Takao Ohtsuka(Department of Surgery and Oncology, Kyushu University, Japan)
Roberto Salvia
Does the size of mural nodule matter to predict malignancy in BD-IPMN? A systematic review of the literature and single high-volume center experience
Roberto Salvia(Pancreas Institute, Department of Surgery, University of Verona, Italy)
Yasuhiro Shimizu
Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas(BD-IPMN)-analysis of 100 pancreatic resection patients at multiple centers
Yasuhiro Shimizu(Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Japan)

IAP International Consensus 4
International Consensus on Borderline Resectable Pancreatic Cancer

AUGUST 5 (13:50-16:20) Room 2(Tachibana, Conference building 2F)

Moderators Shuji Isaji(Mie University Graduate School of Medicine, Japan)
Christopher L. Wolfgang(Johns Hopkins Hospital, USA)
Matthew HG Katz
Borderline resectable pancreatic cancer:Need for standardization and quality control in clinical treatment trials
Matthew HG Katz(Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, USA)
Markus W. Büchler
Borderline resectable pancreatic cancer
Markus W. Büchler(Department of Surgery, University of Heidelberg, Germany)
Claudio Bassi
Borderline resectable pancreatic cancer:the role of neoadjuvant chemotherapy to improve surgical outcome
Claudio Bassi(Surgical and Oncological Department, University of Verona, Italy)
Carlos Fernández
Management of“Borderline Resectable”and“Locally Advanced” pancreatic cancer at the Massachusetts General Hospital
Carlos Fernández - del Castillo(Department of General and Gastrointestinal Surgery, Massachusetts General Hospital/Harvard Medical School, USA)
John A Windsor
Borderline resectable pancreatic cancer:Auckland experience
John A Windsor(HBP/Upper GI Unit, Auckland City Hospital / Department of Surgery, University of Auckland, New Zealand)
Sun-Whe Kim
Reappraisal of portal vein/superior mesenteric vein(PV/SMV)criteria for borderline resectable pancreatic cancer(BRPC)
Sun-Whe Kim(Department of Surgery, Seoul National University Hospital, Korea)
Hirohisa Kitagawa
Histopathological review of resectability of pancreatic ductal adenocarcinoma comparing with CT images for correct decision
Hirohisa Kitagawa(Department of Gastroenterologic Surgery, Toyama City Hospital / Department of Gastroenterologic Surgery, Kanazawa University, Japan)
Masashi Kishiwada
A new resectability definition for borderline resectable pancreatic cancer in general rules for the study of pancreatic cancer(Japan pancreas society 7th edition)
Masashi Kishiwada(Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University School of Medicine, Japan)

IAP International Consensus 5
What is Early Chronic Pancreatitis and Why is Diagnosis Important?

AUGUST 6 (15:00-17:30) Room 2(Tachibana, Conference building 2F)

Moderators Tooru Shimosegawa(Tohoku University Graduate School of Medicine, Japan)
David Clement Whitcomb(University of Pittsburgh, USA)
David Clement Whitcomb
Chronic pancreatitis:Call for adopting a mechanistic definition before establishing diagnostic criteria
David Clement Whitcomb(Division of Gastroenterology, Hepatology and Nutrition, Departments of Medicine, University of Pittsburgh, USA)
Pramod Garg
Early chronic pancreatitis:A conceptual understanding
Pramod Garg(Gastroenterology, All India Institute of Medical Sciences, India)
Alexander Schneider
A new definition of early chronic pancreatitis―What needs to be done?
Alexander Schneider(Department of Medicine II, University Medical Centre Mannheim, University of Heidelberg, Germany)
Luca Frulloni
Proposal of the new definition of CP:Pros & Cons
Luca Frulloni(Department of Medicine, Institute of the Pancreas, University of Verona, Italy)
Tooru Shimosegawa
Diagnostic criteria for early chronic pancreatitis in Japan
Tooru Shimosegawa(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)
Atsushi Masamune
Alcohol as a risk factor for early chronic pancreatitis
Atsushi Masamune(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)
Suresh T Chari
Risk factors for CP:Role in Diagnosis of CP
Suresh T Chari(Mayo Clinic, USA)
Miklos Sahin-Toth
Genetic susceptibility in chronic pancreatitis
Miklos Sahin-Toth(Department of Molecular and Cell Biology, Boston University, USA)
David Clement Whitcomb
Clinical signs of early chronic pancreatitis
David Clement Whitcomb(Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh, USA)
Markus M. Lerch
Diagnostic biomarkers for early chronic pancreatitis
Markus M. Lerch(Department of Medicine A, University Medicine,Ernst-Moritz-Arndt-University of Greifswald, Germany)
Mark Topazian
What is early chronic pancreatitis and why is diagnosis important?
Mark Topazian(Department of Gastroenterology and Hepatology, Mayo Clinic, USA)
Atsushi Irisawa
The role of EUS for diagnosis of early chronic pancreatitis
Atsushi Irisawa(Department of Gastroenterology, Aizu Medical Center, Fukushima Medical University, Japan)
Charles M. Wilcox
Role of ERCP and MRI/MRCP in the diagnosis of early chronic pancreatitis:Not quite there yet
Charles M. Wilcox(Division of Gastroenterology and Hepatology University of Alabama at Birmingham, USA)
Yoshiki Hirooka
Feasibility of Shear wave elastography for the diagnosis of early chronic pancreatitis
Yoshiki Hirooka(Department of Endoscopy, Nagoya University Hospital, Japan)
Symposium
JPS Symposium 1
Advances in Endoscopic Treatment for Pancreatic Diseases

AUGUST 4 (8:30-11:00) Room 1(Main Hall, Conference building 2F)

Moderators Hiroyuki Maguchi(Teine-Keijinkai Hospital, Japan)
Jong H. Moon(Soon Chun Hyang University School of Medicine, Korea)
Martin L. Freeman
Endoscopic therapy of pancreatic disease in 2016:effective by whom and for whom? Withdrawn
Martin L. Freeman(Division of Gastroenterology, Hepatology and Nutrition / Islet Autotransplantation, University of Minnesota, USA)
Jong H. Moon
Endoscopic treatment for pancreatic diseases in Korea
Jong H. Moon(Digestive Disease Center and Research Institute, Department of Internal Medicine, Soon Chun Hyang University School of Medicine, Korea)
辻忠男
Treatment of pancreatic stones by eswl and endoscopy―our experience of 561 cases in 25 years―
Tadao Tsuji(Gastroenterology, Saitama Co-operative Hospital, Japan)
藤森尚
Efficacy of endoscopic transpapillary drainage for patients with pancreatic duct disruption
Nao Fujimori(Department of Gastroenterology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan)
辻忠男
Clinical features of acute obstructive suppurative pancreatic ductitis:a retrospective review of 20 cases
Hiromu Kondo(Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Japan)
菊山正隆
Experiments and strategy for treatment of stenotic pancreatodigestive anastomosis after pancreatoduodenectomy
Masataka Kikuyama(Gastroenterolgy, Shizuoka Genearal Hospital, Japan)
永井一正
Short-type single-balloon enteroscopy-assisted ERCP in patients with pancreaticojejunal anastomotic stricture following pancreaticoduodenectomy
Kazumasa Nagai(Center for gastroenterology, Teine Keijinkai Hospital, Japan)
加藤博也
The feasibility and effectiveness of EUS-guided pancreatic duct drainage
Hironari Kato(Okayama University Hospital, Japan)
三長孝輔
Predictors of pain response in patients undergoing EUS-guided neurolysis for abdominal pain caused by pancreatic cancer
Kosuke Minaga(Department of Gastroenterology and Hepatology, Kinki University, Japan)
Yoshiki Hirooka
Phase 1 dose-escalation clinical trial of EUS-guided injection of HF 10 for unresectable locally advanced pancreatic cancer
Yoshiki Hirooka(Department of Endoscopy, Nagoya University Hospital, Japan)
JPS&IAP Symposium 2
Preoperative Therapy for Pancreatic Cancer

AUGUST 4 (8:30-11:00) Room 3(Hagi, Conference building 2F)

Moderators Hiroki Yamaue (Wakayama Medical University, Japan)
Michiaki Unno (Tohoku University School of Medicine, Japan)
Sun-Whe Kim (Seoul National University Hospital, Korea)
Sun-Whe Kim
Lesson from chemoradiotherapy followed by surgery for borderline and locally advanced pancreatic cancer(BRPC and LAPC)
Sun-Whe Kim(Department of Surgery, Seoul National University Hospital, Korea)
Christopher L. Wolfgang
Preoperative therapy for pancreatic cancer
Christopher L. Wolfgang(Johns Hopkins Hospital, USA)
Yan-Shen Shan
Predictors for resectability and survival in locally advanced pancreatic cancer after Gemcitabine-based neoadjuvant therapy
Yan-Shen Shan(Department of Surgery, National Cheng Kung University Hospital, Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Taiwan)
Fuyuhiko Motoi
Neoadjuvant chemotherapy with gemcitabine and S1(NAC-GS)for Borderline resectable pancreatic cancer
Fuyuhiko Motoi(Department of Surgery, Tohoku University, Japan)
清水敦史
Treatment strategy for borderline resectable pancreatic cancer with radiographic artery involvement
Atsushi Shimizu(Second Department of Surgery, Wakayama Medical University, School of Medicine, Japan)
Sohei Satoi
A clinical role of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
Sohei Satoi(Department of Surgery, Kansai Medical University, Japan)

JPS Symposium 3
Diagnostic Strategy for Early Pancreatic Cancer

AUGUST 4 (15:00-17:30) Room 1(Main Hall, Conference building 2F)

Moderators Keiji Hanada(JA Onomichi General Hospital, Japan)
Masayuki Kitano(Wakayama Medical University, Japan)
Atsushi Kanno
Challenges in early detection of pancreatic cancer
Atsushi Kanno(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)
DongKi Lee
The trend of early diagnosis for pancreatic cancer in Korean and Asian areas
DongKi Lee(Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University, Korea)
Marcia Irene Canto
Value of EUS screening in patients with high risk factors for pancreatic cancer(Focus on familial pancreatic cancer)
Marcia Irene Canto(Medicine and Oncology, Johns Hopkins Medical Institutions, USA)
Reiko Ashida
US screening for early diagnosis of pancreatic cancer
Reiko Ashida(Departments of Cancer Survey and Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Disease, Japan)
Tomoyuki Minami
Diagnosis of pancreatic carcinoma in situ with endoscopic nasopancreatic drainage
Tomoyuki Minami(Department of Gastroenterology, Onomichi General Hospital, Japan)
Takeshi Miyata
Value of EUS and follow-up studies in IPMN cases for early diagnosis of pancreatic cancer
Takeshi Miyata(Department of Surgery, Kinki University, Japan)
Takao Ohtsuka
Diagnostic strategy for early detection of pancreatic ductal adenocarcinoma concomitant with IPMN using ERCP/pancreatic juice cytology
Takao Ohtsuka(Department of Surgery and Oncology, Kyushu University, Japan)
MicroRNA markers for the detection of resectable pancreatic cancer
Shuichi Mitsunaga(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East / Department of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Japan)

JPS Symposium 4
Lap(Robotic)Pancreatectomy

AUGUST 5 (8:15-10:45) Room 1(Main Hall, Conference building 2F)

Moderators Masafumi Nakamura (Graduate School of Medical Sciences, Kyushu University, Japan)
Ho-Seong Han (Seoul National University Bundang Hospital, Korea)
Sponsored Intuitive Surgical G. K.
Herbert J. Zeh
Robotic(computer assisted)pancreatic surgery:A real innovation?
Herbert J. Zeh(Department of Gastrointestinal Surgical Oncology, University of Pittsburgh, USA)
Ho-Seong Han
Updates of laparoscopic pancreas surgery
Ho-Seong Han(Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Korea)
Yoshiharu Nakamura
An educational system based on porcine laparoscopic advanced pancreatectomies for transfer to humans
Yoshiharu Nakamura(Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Japan)
Goro Honda
Safe and clear dissection around the mesenteric vessels utilizing laparoscopic magnified view during pancreaticoduodenectomy
Goro Honda(Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Japan)
Appropriate operative indication during the initial learning curve and surgical approach allowing safe resection in laparoscopic pancreaticoduodenectomy
Yuichi Nagakawa(Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Japan)
後藤直大
Laparoscopic distal pancreatectomy:effects of standardization
Tadahiro Goto(Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University, Japan)
大野慎一郎
The tips of laparoscopic spleen-preserving distal pancreatectomy without preservation of splenic vessels(Warshaw technique)
Shinichiro Ono(Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan)
鈴村和大
Laparoscopic distal pancreatectomy with or without splenectomy:spleen and splenic vessels preservation does not increase morbidity
Kazuhiro Suzumura(Department of Surgery, Hyogo College of Medicine, Japan)
Masafumi Nakamura
Laparoscopic pancreatectomy in Kyushu University and in Japan
Masafumi Nakamura(Department of Surgery and Oncology, Kyushu University, Japan)

JPS&IAP Symposium 5
Basic Research on Pancreatitis

AUGUST 5 (8:15-10:00) Room 3(Hagi, Conference building 2F)

Moderators Kyoko Shimizu (Tokyo Women’s Medical University, School of Medicine, Japan)
Julia Mayerle (University Medicine, Ernst-Moritz-Arndt-University of Greifswald, Germany)
Ashok K Saluja
Relative contribution of trypsin and inflammation in pancreatitis
Ashok K Saluja(Department of Surgery and Sylvester Comprehensive Cancer Center, University of Miami, USA)
Hyeyoung Kim
Signaling in pancreatic acinar and stellate cells in the pathogenesis of pancreatitis
Hyeyoung Kim(Department of Food and Nutrition, Yonsei University, Korea)
Stephen Pandol
Metabolic stressors and pancreatic disease
Stephen Pandol(Cedars-Sinai Medical Center / University of California / Department of Veterans Affairs, USA)
Masaki Ohmuraya
The roles of cathepsin B, D, and L during acute and chronic pancreatitis in mice
Masaki Ohmuraya(Institute of Resource Development and Analysis, Kumamoto University, Japan)
Robert Sutton
Drug discovery and development for acute pancreatitis
Robert Sutton(Royal Liverpool University Hospital/Institute of Translational Medicine, University of Liverpool, UK)
Julia Mayerle
Translational aspects of chronic pancreatitis
Julia Mayerle(Department of Medicine A, University Medicine, Ernst-Moritz-Arndt-University Greifswald, Germany)
Jeremy Wilson
Specail Remarks;Alcoholic pancreatitis in the modern era
Jeremy Wilson(South Western Sydney Clinical School, University of New South Wales, Australia)

JPS&IAP Symposium 6
Treatment of Local Complication of Severe Acute Pancreatitis

AUGUST 5 (13:50-16:20) Room 1(Main Hall, Conference building 2F)

Moderators Yoshifumi Takeyama(Kinki University Faculty of Medicine, Japan)
Santhi Swaroop Vege(Mayo Clinic, USA)
Santhi Swaroop Vege
Classification and diagnosis of local complications of acute pancreatitis
Santhi Swaroop Vege(Mayo Clinic, USA)
Takao Itoi
Interventions of local complication of severe acute pancreatitis
Takao Itoi(Department of Gastroenterology and Hepatology, Tokyo Medical University, Japan)
Surinder Singh Rana
Diagnosis and approach of infected WON
Surinder Singh Rana(Department of Gastroenterology, Postgradute Institute of Medical Education and Research, India)
Yu-Chung Chang
Will Necrosectomy Be an Obsolete Procedure for the Management of Infected Necrotizing Pancreatitis?
Yu-Chung Chang(Surgery, National Cheng Kung University, Japan)
Peter Hegyi
CFTR:A new horizon in the pathomechanism and treatment of pancreatitis
Peter Hegyi(Institute for Translational Medicine, University of Pecs, Hungary)
Nationwide survey of the treatment of local complications of severe acute pancreatitis in Japan
Masaru Koizumi(Department of Surgery, Jichi Medical University School of Medicine, Japan)
大本俊介
EUS-guided interventions for walled-off pancreatic necrosis:clinical outcomes of a step-up approach and risk factors for failed endoscopic treatment
Shunsuke Omoto(Department of Gastroenterology and Hepatology, Kinki university, Japan)
Shin Hamada
Trend in the treatment of walled-off necrosis;from nationwide epidemiological survey data of acute pancreatitis in Japan
Shin Hamada(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)

JPS&IAP Symposium 7
Basic Research on Carcinogenesis

AUGUST 5 (13:50-15:50) Room 3(Hagi, Conference building 2F)

Moderators Shinichi Yachida (National Cancer Center Hospital Research Institute, Japan)
Jingxuan Yang (The University of Oklahoma Health Sciences Center, USA)
Minoti Apte
Stromal remodeling in pancreatic cancer
Minoti Apte(Pancreatic Research Group, South Western Sydney Clinical School, University of New South Wales / Ingham Institute for Applied Medical Research, Australia)
Stephen Pandol
Experimental approach to determine the effects of diet, alcohol and smoking on pancreatic carcinogenesis
Stephen Pandol(Cedars-Sinai Medical Center / University of California / Department of Veterans Affairs, USA)
Jingxuan Yang
ZIP4 regulates pancreatic cancer cachexia and post-surgical survival through activation of P38 pathway
Jingxuan Yang(Department of Internal Medicine, The University of Oklahoma Health Sciences Center, USA)
Hideaki Ijichi
Crucial Roles of BMP signaling in pancreatic cancer initiation and progression
Hideaki Ijichi(Department of Clinical Nutrition Therapy, The University of Tokyo / Department of Gastroenterology, The University of Tokyo, Japan)
Yuki Shibayama
(Pro)renin receptor is pivotal for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma
Yuki Shibayama(Department of pharmacology, Kagawa University, Japan)
Mitsuro Kanda
Mutational status in precursor lesions of pancreatic cancer;highlighting its diagnostic value
Mitsuro Kanda(Department of Gastroenterological Surgery(Surgery II), Nagoya University, Japan)
Shin Hamada
Impact of Nrf2 on pancreatic carcinogenesis in mice
Shin Hamada(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan)
山口洋志
Induction of R201C Mutant Gαs Modifies Mutant Kras-driven Murine Pancreatic Tumorigenesis and Leads to Differentiated Ductal Phenotypes
Hiroshi Yamaguchi(Sheikh Ahmed Center for Pancreatic Cancer Research, University of Texas, MD Anderson Cancer Center / Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Japan)

JPS Symposium 8
Advances for Chemotherapy in Pancreatic Cancer

AUGUST 6 (8:15-10:45) Room 1(Main Hall, Conference building 2F)

Moderators Junji Furuse(Kyorin University School of Medicine, Japan)
Koji Yamaguchi(Fujimoto General Hospital, Japan)
Systematic review of resection rates and clinical outcomes after FOLFIRINOX-based treatment in patients with locally advanced pancreatic cancer
Steffi Rombouts(Surgery, University Medical Center Utrecht, Netherlands)
石井優
FOLFIRINOX therapy in the elderly patients with unresectable pancreatic cancer
Yu Ishii(Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Japan)
Phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer(MPC)
Masato Ozaka(The Cancer Institute Hospital of JFCR, Japan)
Clinical outcome of Gemcitabine and Nab-paclitaxel therapy in unresectable pancreatic cancer at high-volume cancer center institution
Yusuke Hashimoto(Hepatobiliary and pancreatic oncology, National Cancer Center East Hospital, Japan)
上野誠
The retrospective analysis of gemcitabine+nab-paclitaxel for the treatment of advanced pancreatic cancer
Makoto Ueno(Department of gastroenterology, Hepatobiliary and pancreatic division, Kanagawa Cancer Center, Japan)
高見秀樹
Experience of gemcitabine plus nab-paclitaxel combination therapy in second line and beyond for unresectable progressive and metastatic pancreatic cancer
Hideki Takami(Department of Gastroenterological surgery, Nagoya University Graduate School of Medicine, Japan)
山井琢陽
Serum alkaline phosphatase may predict the severity of non-hematologic toxicity in pancreatic cancer patients with Gemcitabine plus nab-Paclitaxel
Takuo Yamai(Department of gastroenterology and hepatology, Osaka University, Japan)
Nab-paclitaxel and gemcitabine decrease cancer-associated fibroblasts through pancreatic stromal depletion
Tomoharu Miyashita(Department of Gastroenterological Surgery, Kanazawa University Hospital, Japan)
高原楠昊
A multi-center phase II study of intravenous and intraperitoneal paclitaxel with S-1 for pancreatic cancer patients with peritoneal metastasis
Naminatsu Takahara(Department of Gastroenterology, Graduate School of Medicine, the University of Tokyo, Japan)
The outcome of responders to initial chemoradiotherapy or chemotherapy for locally advanced pancreatic cancer
Kentaro Sudo(Department of Gastroenterology, Chiba Cancer Center, Japan)
藤井努
Clinical Benefits of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head:A Dual-institution Observational Study using IPTW
Tsutomu Fujii(Department of Gastroenterological Surgery(Surgery II), Nagoya University Graduate School of Medicine, Japan)
Clinical significance of conversion surgery after gemcitabine plus S-1 based chemoradiotherapy in patients with initially locally advanced unresectable pancreatic adenocarcinoma:application of intratumoral expression of Tenascin C as a surrogate marker
Yasuhiro Murata(Department of Hepato-biliary Pancreatic and Transplant Surgery, Mie University, Japan)
Clinical impact of Gemcitabine with S-1 and chemoradiation concomitant S-1 for locally advanced unresectable pancreatic cancer
Kosei Maemura(Department of Digestive Surgery, Kagoshima University, Japan)

AOPA Symposium 9
Pancreatology in Asia-Oceania

AUGUST 6 (8:15-10:45) Room 2(Tachibana, Conference building 2F)

Moderators Masanori Sugiyama(Kyorin University, Japan)
Pramod Garg(All India Institute of Medical Sciences, India)
Pramod Garg
Chronic Pancreatitis in Asia-Oceania:Epidemiology and Etiopathogenesis
Pramod Garg(Gastroenterology, All India Institute of Medical Sciences, India)
Kazuichi Okazaki
Recent Advances in Etiopathogenic Researches in Autoimmune Pancreatitis in Japan
Kazuichi Okazaki(Department of Gastroenterology and Hepatology, Kansai Medical University, Japan)
Myung-Hwan Kim
Revised Atlanta Classification and Determinant-Based Classification:Which one better reflects outcomes of patients with acute pancreatitis?
Myung-Hwan Kim(Division of Gastroenterology, University of Ulsan College of Medicine, Korea)
Minoti Apte
Alcohol, smoking and pancreas
Minoti Apte(Pancreatic Research Group, South Western Sydney Clinical School, University of New South Wales / Ingham Institute for Applied Medical Research, Australia)
Tsann Long Hwang
Update Research and Clinical Advances of Pancreatology in Taiwan
Tsann Long Hwang(Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taiwan)

JPS&IAP Symposium 10
Precursor Lesions in the Pancreas-Current Concepts

AUGUST 6 (8:15-10:00) Room 3(Hagi, Conference building 2F)

Moderators Toru Furukawa(Tokyo Women’s Medical University, Japan)
Laura DeLong Wood(Johns Hopkins University School of Medicine, USA)
Laura DeLong Wood
Genomic analyses of pancreatic cancer precursor lesions
Laura DeLong Wood(Department of Pathology, Johns Hopkins University School of Medicine, USA)
Noriyoshi Fukushima
Overview of the Baltimore consensus
Noriyoshi Fukushima(Department of Pathology, Jichi Medical University Hospital, Japan)
Seung-Mo Hong
Updates and issues of pancreatic precursor lesions:Pathologist’s perspective
Seung-Mo Hong(Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Korea)
Hiroshi Yamaguchi
Intraductal tubulopapillary neoplasm, a novel precursor of invasive carcinoma of the pancreas
Hiroshi Yamaguchi(Department of Anatomic Pathology, Tokyo Medical University, Japan)
Toru Furukawa
Impacts of a mutated GNAS on clinicopathology of intraductal papillary mucinous neoplasms of the pancreas
Toru Furukawa(Institute for Integrated Medical Sciences, Tokyo Women’s Medical University, Japan)

JPS Symposium 11
Recent Innovation in Pancreatic Surgery

AUGUST 6 (15:00-17:30) Room 1(Main Hall, Conference building 2F)

Moderators Masanori Sugiyama(Kyorin University, Japan)
Sun-Whe Kim(Seoul National University Hospital, Korea)
Vikas Kumar Dudeja
Irreversible electroporation for pancreatic cancer:Is it worth the hype?
Vikas Kumar Dudeja(Division of Surgical Oncology, Department of Surgery, University of Miami, USA)
Appropriate dissection based on the anatomical feature of the mesopancreas in the pancreatic head cancer
Yatsuka Sahara(Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Japan)
Masanori Sugiyama
Intestinal derotation procedure for facilitating pancreatoduodenectomy
Masanori Sugiyama(Department of Surgery, Kyorin University, Japan)
Development of suture-assistance devices that facilitate pancreaticojejunostomy:outcomes of early clinical study
Tomio Ueno(Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University, Japan)
Pancreaticoduodenectomy with simultaneous resection of the artery and portal vein for locally advanced pancreatic cancer
Ryusei Matsuyama(Department of Gastroenterological Surgery, Yokohama City University, Japan)
The impact of pancreaticojejunostomy for pancreatic stump during distal pancreatectomy to reduce pancreatic fistula―A multicenter randomized controlled trial―
Manabu Kawai(Second Department of Surgery, Wakayama Medical University, Japan)

JPS&IAP Symposium 12
Familial Pancreatic Cancer Registry and Its Implication to Clinical Managements

AUGUST 6 (15:00-17:30) Room 3(Hagi, Conference building 2F)

Moderators Kyoichi Takaori(Kyoto University Hospital, Japan)
Marcia Irene Canto(Johns Hopkins Medical Institutions, USA)
Marcia Irene Canto
Early detection of PC in high risk individuals
Marcia Irene Canto(Medicine and Oncology, Johns Hopkins Medical Institutions, USA)
森実千種
Japanese familial pancreatic cancer registry by Japan Pancreas Society
Chigusa Morizane(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Japan)
Laura DeLong Wood
Target lesions for early detection of pancreatic cancer
Laura DeLong Wood(Department of Pathology, Johns Hopkins University School of Medicine, USA)
北野雅之
Expert consensus on surveillance methods for early detection of familial pancreatic cancer in Japan
Masayuki Kitano(Second Department of Internal Medicine, School of Medicine, Wakayama Medical University, Japan)
Christopher L. Wolfgang
Surgical managements of PanIN and IPMN in high-risk individuals
Christopher L. Wolfgang(Johns Hopkins Hospital, USA)

International (IAP/EPC/APA/JPS)
Symposium CP Guidelines

The International (IAP/EPC/APA/JPS) Chronic Pancreatitis Guidelines Working Group Meeting

AUGUST 6 (13:10-15:00) Room 2(Tachibana, Conference building 2F)

Moderators John Neoptolemos(The Owen and Ellen Evans Chair of Surgery, the University of Liverpool and the Royal Liverpool and Broadgreen University Hospitals NHS Trust 20th, England)
David C. Whitcomb(Division of Gastroenterology, Hepatology and Nutrition, Departments of Medicine, University of Pittsburgh, USA)
Tooru Shimosegawa(Tohoku University Graduate School of Medicine, Japan)
David C. Whitcomb
The definition and diagnosis of Chronic Pancreatitis (CP) – an update on the mechanistic definition following EPC and PANCfest:
David C. Whitcomb (Division of Gastroenterology, Hepatology and Nutrition, Departments of Medicine, University of Pittsburgh, USA)
Peter Hegyi
Risk factors for CP
Peter Hegyi (Institute for Translational Medicine, University of Pecs, Hungary)
Stephen Pandol
The role of EUS in CP
Stephen Pandol (Cedars-Sinai Medical Center / University of California / Department of Veterans Affairs, USA)
The histopathology of CP
John Windsor (HBP/Upper GI Unit, Auckland City Hospital / Department of Surgery, University of Auckland, New Zealand)
Markus M. Lerch
The medical management of CP
Markus M. Lerch (Cedars-Sinai Medical Center / University of California / Department of Veterans Affairs, USA)
Masayuki Kitano
Interventional Endoscopy
Masayuki Kitano (Wakayama Medical University, Japan)

Satellite Symposium

JPS&IAP Satellite Symposium
Classification of Pancreatic Cancer―New JPS Classification:7th Edition

AUGUST 7 (9:00-11:30) Room 2(Tachibana, Conference building 2F)

Moderators Shuji Isaji(Mie University Graduate School of Medicine, Japan)
Hiroki Yamaue(Wakayama Medical University, Japan)
Christopher L. Wolfgang
Classification of pancreatic cancer:AJCC classification Withdrawn
Christopher L. Wolfgang(Johns Hopkins Hospital, USA)
Markus W. Büchler
Classification of pancreatic cancer:problem and proposal for N staging
Markus W. Büchler(Department of Surgery, University of Heidelberg, Germany)
Yan-Shen Shan
Classification of pancreatic cancer:problem and proposal for T staging
Yan-Shen Shan(Department of Surgery, National Cheng Kung University Hospital, Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Taiwan)
藤井努
TNM staging system of pancreatic cancer:new JPS classification
Tsutomu Fujii(Department of Gastroenterological Surgery(Surgery II), Nagoya University Graduate School of Medicine, Japan)
Comparative study of preoperative CT images and pathological findings
Toshifumi Gabata(Department of Radiology, Kanazawa University Hospital, Japan)
Hirohisa Kitagawa
Resectability of pancreatic cancer:new JPS classification
Hirohisa Kitagawa(Department of Gastroenterologic Surgery, Toyama City Hospital / Department of Gastroenterologic Surgery, Kanazawa University, Japan)
Noriyoshi Fukushima
Pathological classification of pancreatic neoplasm:new JPS classification
Noriyoshi Fukushima(Department of Pathology, Jichi Medical University Hospital, Japan)
内田克典
Evaluation of histological response after preoperative therapy:new JPS classification
Katsunori Uchida(Department of Oncologic pathology, Mie University Graduate School of Medicine, Japan)
Hands-on Seminar (Japanese Only)
JPS Hands-on Seminar 1
Hands-on Seminar for Endoscopic Procedure

AUGUST 4 (14:10-16:10) Hands-on Room (Lecture Room, Conference building 1F)

Moderators Takao Itoi(Tokyo Medical University Hospital, Japan)
Hiroyuki Inoue(Mie University Graduate School of Medicine, Japan)
Sponsored Olympus Corporation / Boston Scientific Japan K. K.
JPS Hands-on Seminar 2
Hands-on Seminar for Laparoscopic Pancreatic Surgery

AUGUST 5 (13:50-15:50) Hands-on Room (Lecture Room, Conference building 1F)

Moderators Goro Honda(Tokyo Metropolitan Cancer and Infectious DiseasesCenter Komagome Hospital, Japan)
Takanori Morikawa(Tohoku University School of Medicine, Japan)
Sponsored Johnson and Johnson K. K.
Morning Seminar (Japanese Only)
JPS Morning Seminar 1
Medical writing in English

AUGUST 5 (7:40-8:10) Room 5(Shirakashi 2, Conference building 3F)

Moderator Kyoichi Takaori(Kyoto University Hospital, Japan)
Sponsored MRT Inc.
Lecturer Masanori Sugiyama(Department of Surgery, Kyorin University, Japan)
JPS Morning Seminar 2
How to write an original paper in English:significance of Tariki(The Power-Beyond-Self)

AUGUST 6 (7:40-8:10) Room 5(Shirakashi 2, Conference building 3F)

Moderator Kyoichi Takaori(Kyoto University Hospital, Japan)
Sponsored MRT Inc.
Lecturer Shuji Isaji(Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Japan)
IAP & JPS & AOPA 2016 Award

The ceremony of IAP & JPS & AOPA 2016 Award will be held in Gala Party on August 5.

Young Investigator Award

AUGUST 4(14:10-16:45) Room 3(Hagi, Conference building 2F)

Moderators
(YIA-1-7)
Kyoko Miyasaka(Department of Physiology and Nutrition, Graduate School of Tokyo Kasei University, Japan)
Masaru Miyazaki(International University of Health and welfare, Mita Hospital, Japan)
Stephen Pandol(Cedars-Sinai Medical Center / University of California / Department of Vaterans Affairs, USA)
Moderators
(YIA-8-14)
Keiko Shiratori(Pancreatic Research Foundation of Japan, Japan)
Akimasa Nakao(Department of Surgery, Nagoya Central Hospital, Japan)
Markus W. Büchler(Department of Surgery, University of Heidelberg, Germany)
Resident Award
Medical Staff Award
PanCAN Award

The ceremony of PanCAN Award will be held in Gala Party on August 5.

PanCAN Award

AUGUST 4(16:45-17:35) Room 3(Hagi, Conference building 2F)

Moderators Kyoichi Takaori(Pancreatic Cancer Unit, Kyoto University Hospital, Japan)
Junji Furuse(Department of Medical Oncology, Kyorin UniversitySchool of Medicine, Japan)
Luncheon Seminar
Luncheon Seminar 1

AUGUST 4 (12:00-12:50) Room 2(Tachibana, Conference building 2F)

Moderator Masao Tanaka(Shimonoseki City Hospital, Japan)
Sponsored Yakult Honsha Co., Ltd.
Current status of FOLFIRINOX for unresectable pancreatic cancer in Japan
Akira Fukutomi(Shizuoka Cancer Center, Japan)
Luncheon Seminar 2

AUGUST 4 (12:00-12:50) Room 3(Hagi, Conference building 2F)

Moderator Junji Furuse(Kyorin University School of Medicine, Department of Medical Oncology, Japan)
Sponsored Pfizer Japan Inc.
The role of targeted therapy in pancreatic neuroendocrine tumors.
Chigusa Morizane(National Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology(Rare Cancer Center), Japan)
Luncheon Seminar 3

AUGUST 4 (12:00-12:50) Room 4(Shirakashi 1, Conference building 3F)

Moderator Keiko Shiratori(Pancreatic Reseach Foundation of Japan, Japan)
Sponsored Japan Blood Products Organization
Prevention and treatment of complications after pancreatic surgery ~with treatment of severe infection~
Takashi Hatori(Department of Digestive Diseases Center, International University of Health and Welfare, Mita Hospital, Japan)
Luncheon Seminar 4

AUGUST 4 (12:00-12:50) Room 5(Shirakashi 2, Conference building 3F)

Moderator Kazuo Inui(Fujita Health University School of Medicine, Japan)
Sponsored EA Pharma Co., Ltd.
Emerging concept of management for chronic pancreatitis from the evidence-based clinical practice guidelines 2015 in Japan
Tetsuhide Ito(Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan)
Luncheon Seminar 5

AUGUST 4 (12:00-12:50) Room 6(Meeting Room 4, Exhibition building)

Moderator Akimasa Nakao(Nagoya Central Hospital, Japan)
Sponsored Covidien Japan, Inc.
Clinical trials to reduce pancreatic fistula after distal pancreatectomy
Manabu Kawai(Second Department of Surgery, Wakayama Medical University, Japan)
Luncheon Seminar 6

AUGUST 4 (12:00-12:50) Room 7(Meeting Room 3, Exhibition building)

Moderator Tsuyoshi Sano(Department of Gastroenterological Surgery, Aichi Medical University, Japan)
Sponsored Taiho Pharmaceutical Co., Ltd.
What should be the future of the pancreatic surgery?
Tsutomu Fujii(Department of Gastroenterological Surgery,(Surgery II)Nagoya University Graduate School of Medicine, Japan)
Luncheon Seminar 7

AUGUST 5 (11:40-12:30) Room 2(Tachibana, Conference building 2F)

Moderator Hiroki Yamaue(Second Department of Surgery, Wakayama Medical University School of Medicine, Japan)
Sponsored Taiho Pharmaceutical Co., Ltd.
Current and Future Strategies for the Treatment of Locally Advanced Pancreatic Cancer
Matthew HG Katz(Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, USA)
Luncheon Seminar 8

AUGUST 5 (11:40-12:30) Room 3(Hagi, Conference building 2F)

Moderator Kenji Yamao(Senior Advisor of Narita Memorial Hospital, Japan)
Sponsored Novartis Pharma K.K.
Values and issues on EUS guided fine needle aspiration for diagnosis of pancreatic neuroendocrine neoplasm
Keiji Hanada(Department of Gastroenterology, Onomichi General Hospital, Japan)
Luncheon Seminar 9

AUGUST 5 (11:40-12:30) Room 4(Shirakashi 1, Conference building 3F)

Moderator Itaru Endo(Department of Gastroenterological Surgery Yokohama City University, Japan)
Sponsored Taisho Toyama Pharmaceutical Co., Ltd.
Aggressive surgical resection for locally advanced pancreatic cancer combining with current chemotherapy protocols.
Hideyuki Yoshitomi(Department of General Surgery, Chiba University, Graduate School of Medicine, Chiba, Japan)
Luncheon Seminar 10

AUGUST 5 (11:40-12:30) Room 5(Shirakashi 2, Conference building 3F)

Moderator Tetsuhide Ito(Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan)
Sponsored EA Pharma Co., Ltd.
Management of chronic pancreatitis in Japan -Current status and perspectives of“early chronic pancreatitis”-
Atsushi Masamune(Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan
Luncheon Seminar 11

AUGUST 5 (11:40-12:30) Room 6(Meeting Room 4, Exhibition building)

Moderator Teruo Nakamura(Health Care Center, Hirosaki Medical Association, Japan)
Sponsored Amano Enzyme Inc.
Pancreatic Enzyme and Insulin Replacement Therapy for Patients with Pancreatic Disease
Yusuke Tando(Hirosaki University, Graduate School of Health Sciences, Division of Medical Life Science, Japan)
Luncheon Seminar 12

AUGUST 5 (11:40-12:30) Room 7(Meeting Room 3, Exhibition building)

Moderator Junichi Sakagami(Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Japan)
Sponsored Ajinomoto Co., Inc.
Profile of plasma free amino acids in cancer patients:Could it be a biomarker?
Yohei Miyagi(Molecular Pathology and Genetics Division Kanagawa Cancer Center Research Institute, Japan)
The clinical significance of the Plasma Free Amino Acid Profile in diagnosis of Pancreatic cancer.
Kazuhiro Katayama(Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan)
Luncheon Seminar 13

AUGUST 6 (12:10-13:00) Room 2(Tachibana, Conference building 2F)

Moderator Yoshifumi Takeyama(Department of Surgery Kinki University Faculty of Medicine, Japan)
Sponsored EA Pharma Co., Ltd.
Devices for improvement of long-term prognosis after pancreatetcomy
Fuyuhiko Motoi(Department of Surgery, Tohoku University School of Medicine, Japan)
Hiroshi Ikegami(Department of Endocrinology, Metabolism and Diabetes Kinki University Faculty of Medicine, Japan)
Luncheon Seminar 14

AUGUST 6 (12:10-13:00) Room 3(Hagi, Conference building 2F)

Moderator Naohiro Sata(Department of Gastroenterological and General Surgery, Jichi Medical University, Japan)
Sponsored Johnson & Johnson K.K.
How to standardize laparoscopic pancreatectomy?
Yoshiharu Nakamura(Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Japan)
Luncheon Seminar 15

AUGUST 6 (12:10-13:00) Room 4(Shirakashi 1, Conference building 3F)

Moderator Kazuichi Okazaki(Department of Gastroenterology and Hepatology, Kansai Medical University, Japan)
Sponsored Chugai Pharmaceutical Co., Ltd.
Treatment strategy for pancreatic cancer ―overview and translational approach―
Hideyuki Hayashi(Division of clinical cancer genomics Hokkaido University Hospital, Japan)
Luncheon Seminar 16

AUGUST 6 (12:10-13:00) Room 5(Shirakashi 2, Conference building 3F)

Moderator Hirohide Ohnishi(Japan Organization of Occupational Health and Safety, Japan)
Sponsored ASAHI KASEI PHARMA CORPORATION
Clinical experience of recombinant Thrombomodulin(rTM)in severe acute pancreatitis
Takaaki Eguchi(Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan)
Relationship between severity assessments and DIC score in patients with acute pancreatitis
Junichi Sakagami(Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Japan)
Luncheon Seminar 17

AUGUST 6 (12:10-13:00) Room 6(Meeting Room 4, Exhibition building)

Moderator Hitoshi Yoshida(Department of Medicine, Division of Gastroenterology, Showa University School of Medicine, Japan)
Sponsored MIYARISAN PHARMACEUTICAL CO., LTD.

Current nutrition therapy during serious stage of digestive diseases
~The views of two Japanese specialists~

Nutritional management in acute pancreatitis- Up to date
Katsuya Kitamura(Department of Medicine, Division of Gastroenterology, Showa University School of Medicine, Japan)
Synbiotics as tube feeding ~Recent review~
Naohiro Washizawa(Clinical Support Service Section, Toho University school of medicine, Japan)
Coffee Break Seminar
Coffee Break Seminar 1

AUGUST 4 (9:30-10:00) Room 5(Shirakashi 2, Conference building 3F)

Moderator Tadahiro Takada(Teikyo University School of Medicine, Japan)
Sponsored Shionogi & Co., Ltd.
Revised points of the Japanese guidelines for the manegement of acute pancreatitis 2015
Masahiro Yoshida(Department of Surgery and Hemodialysis KAKEN Hospital. International University of Health and Welfare, Japan)
Coffee Break Seminar 2

AUGUST 4 (16:00-16:30) Room 5(Shirakashi 2, Conference building 3F)

Moderator Keisho Kataoka(Otsu Municipal Hospital, Japan)
Sponsored DAIICHI SANKYO COMPANY, LIMITED
“Japanese Guidelines for GERD 2015”
Shuichi Ohara(Tohoku Rosai Hospital, Japan)
Coffee Break Seminar 3

AUGUST 5 (9:15-9:45) Room 5(Shirakashi 2, Conference building 3F)

Moderator Hiroyuki Miyatani(Department of Gastroenterology Jichi Medical University Saitama Medical Center, Japan)
Sponsored FUJIFILM Medical Co., Ltd.
New challenge on biliary pancreatic endoscopic treatment ~Clinical benefits of the DBE for the patients with reconstructed gastrointestinal anatomy~
Masaaki Shimatani(The Third Department of Internal Medicine Division of Gastroenterology and Hepatology Kansai Medical University, Japan)





PageTOP